Raynaud's phenomenon as a manifestation of parvovirus B19 infection: Case reports and review of parvovirus B19 rheumatic and vasculitic syndromes

被引:37
作者
Harel, L
Straussberg, R
Rudich, H
Cohen, AH
Amir, J
机构
[1] Schneider Childrens Med Ctr Israel, Dept Pediat C, IL-49202 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Minist Hlth, Publ Hlth Labs, Cent Virol Lab, Tel Hashomer, Israel
[4] Berkman Ambulatory Day Care Ctr, Petah Tiqwa, Israel
关键词
D O I
10.1086/313712
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection with human parvovirus B19 is manifested as erythema infectiosum, transient aplastic crisis, or hydrops fetalis, Rheumatic manifestations include arthropathy and various vasculitic syndromes. Isolated Raynaud's phenomenon due to parvovirus B19 has never been described. We report on 2 previously healthy sisters with new-onset Raynaud's phenomenon accompanied by severe generalized polyarthralgia, A full workup was negative, except serology for parvovirus B19, which was positive. Air symptoms gradually subsided within 3-5 months, and no recurrence has been noted during the 3 years since onset. We review all the studies in the English-language literature on parvovirus B19-induced rheumatic and vasculitic syndromes. We hypothesize that the pathogenesis of Raynaud's phenomenon in our patients involved immune-mediated endothelial damage leading to platelet activation and vasoconstriction. We recommend that in cases of unexplained Raynaud's phenomenon, serology for parvovirus B19 be included in the evaluation.
引用
收藏
页码:500 / 503
页数:4
相关论文
共 46 条
[1]   EPIDEMIC ERYTHEMA INFECTIOSUM [J].
AGER, EA ;
CHIN, TDY ;
POLAND, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (24) :1326-&
[2]   HUMAN PARVOVIRUSES [J].
ANDERSON, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :603-608
[3]  
Cooper CL, 1998, CLIN INFECT DIS, V26, P849
[4]   POLYARTERITIS-NODOSA AND PARVOVIRUS-B19 INFECTION [J].
CORMAN, LC ;
DOLSON, DJ .
LANCET, 1992, 339 (8791) :491-491
[5]   ASSOCIATION OF WEGENER GRANULOMATOSIS WITH PARVOVIRUS B19 INFECTION - COMMENT [J].
CORMAN, LC ;
STAUD, R .
ARTHRITIS AND RHEUMATISM, 1995, 38 (08) :1174-1175
[6]  
FawazEstrup F, 1996, J RHEUMATOL, V23, P1180
[7]   CHRONIC PARVOVIRUS B19 INFECTION AND SYSTEMIC NECROTIZING VASCULITIS - OPPORTUNISTIC INFECTION OR ETIOLOGIC AGENT [J].
FINKEL, TH ;
TOROK, TJ ;
FERGUSON, PJ ;
DURIGON, EL ;
ZAKI, SR ;
LEUNG, DYM ;
HARBECK, RJ ;
GELFAND, EW ;
SAULSBURY, FT ;
HOLLISTER, JR ;
ANDERSON, LJ .
LANCET, 1994, 343 (8908) :1255-1258
[8]   EVALUATION OF A SYNTHETIC-PEPTIDE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR IMMUNOGLOBULIN-M TO HUMAN PARVOVIRUS-B19 [J].
FRIDELL, E ;
COHEN, BJ ;
WAHREN, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (07) :1376-1381
[9]   INFLUENCE OF PREVIOUS EXPOSURE TO HUMAN PARVOVIRUS B19 INFECTION IN EXPLAINING SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS - AN ANALYSIS OF DISEASE DISCORDANT TWIN PAIRS [J].
HAJEER, AH ;
MACGREGOR, AJ ;
RIGBY, AS ;
OLLIER, WER ;
CARTHY, D ;
SILMAN, AJ .
ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (02) :137-139
[10]   PETECHIAL GLOVE AND SOCK SYNDROME CAUSED BY PARVOVIRUS B19 [J].
HALASZ, CLG ;
CORMIER, D ;
DEN, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (05) :835-838